Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Oncolytics Biotech (ONCY)

Annual Return

Over the past 3 years, ONCY has had an average annual return of -20.03%, underperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, ONCY has had an average annual return of -22.04%, underperforming the benchmark SPY, which returned +13.88% annual.

Since May 31, 2018, ONCY has had an average annual return of -21.46%, underperforming the benchmark SPY, which returned +15.40% annual.

202620252024202320222021202020192018
+0.70%-4.34%-32.31%-17.18%+17.24%-41.59%-49.99%+162.99%-70.33%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+12.21%+15.17%-24.89%+3.74%+18.16%-15.37%+0.70%
2025-20.23%-9.37%-16.71%+3.77%-40.49%+127.47%+31.97%+1.97%+34.60%-14.99%-16.25%-12.30%-4.34%
2024-11.84%-4.20%-7.01%+4.72%-3.63%-7.47%+5.05%-7.80%-9.16%+32%-19.10%-1.77%-32.31%
2023+9.21%-14.05%-21.57%+21.66%+10.99%+60.47%-3.07%-9.13%-4.79%-23.87%-12.64%-6.90%-17.18%
2022+36.68%-10.53%-7.07%-16.45%-11.37%-13.66%+13.59%+25.15%-14.36%+2.48%+39.64%-7.38%+17.24%
2021+5.02%+28.40%+18.70%-19.95%+0%-9.18%-16.25%-0.42%-9.53%-2.39%-17.17%-17.73%-41.59%
2020-44.96%-22.91%-31.68%+19.58%+47.87%-22.95%+7.43%-12.87%-3.99%+23.68%+66.99%-31.80%-49.99%
2019+15.47%-2.63%-8.60%+2.69%-9.93%-1.17%-21.17%-55.08%-5.27%+119.14%-10.40%+325%+162.99%
2018+0%-9.84%-9.82%-15.73%-7.65%-20.46%-14.98%-30.66%-70.33%

Drawdown analysis of Oncolytics Biotech (ONCY)

The maximum drawdown for the ONCY was -95.37%, occurring on Jun 5, 2025. This drawdown has not yet recovered.

The current ONCY drawdown is -87.77%.

Since May 31, 2018 ONCY has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-95.37%Jun 7, 20181758Jun 5, 2025OngoingOngoingOngoing
-0.16%Jun 1, 20181Jun 4, 20181Jun 5, 20182